These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15754010)

  • 1. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma.
    Ashida S; Nishimori I; Tanimura M; Onishi S; Shuin T
    J Cancer Res Clin Oncol; 2002 Oct; 128(10):561-8. PubMed ID: 12384800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
    Duivenvoorden WC; Hopmans SN; Gallino D; Farrell T; Gerdes C; Glennie D; Lukka H; Pinthus JH
    Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.
    Grabmaier K; A de Weijert MC; Verhaegh GW; Schalken JA; Oosterwijk E
    Oncogene; 2004 Jul; 23(33):5624-31. PubMed ID: 15184875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX.
    Kopacek J; Barathova M; Dequiedt F; Sepelakova J; Kettmann R; Pastorek J; Pastorekova S
    Biochim Biophys Acta; 2005 May; 1729(1):41-9. PubMed ID: 15833446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.
    Kaluz S; Kaluzová M; Chrastina A; Olive PL; Pastoreková S; Pastorek J; Lerman MI; Stanbridge EJ
    Cancer Res; 2002 Aug; 62(15):4469-77. PubMed ID: 12154057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MN/CA IX antigen as a potential target for renal cell carcinoma].
    Uemura H; Cho M; Nakagawa Y; Shimizu K; Yoshikawa M; Kim S; Hirao Y
    Hinyokika Kiyo; 2000 Oct; 46(10):745-8. PubMed ID: 11215204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
    Nakagawa Y; Uemura H; Shimizu K; Cho M; Yoshikawa M; Hirao Y; Yoshikawa K
    Hinyokika Kiyo; 2001 Nov; 47(11):809-14. PubMed ID: 11771176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter.
    Ou YC; Gardner TA; Kao C; Zhau HE; Chung LW
    Anticancer Res; 2005; 25(2A):881-6. PubMed ID: 15868923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the MN/CA9 gene is associated with hypomethylation in human renal cell carcinoma cell lines.
    Cho M; Grabmaier K; Kitahori Y; Hiasa Y; Nakagawa Y; Uemura H; Hirao Y; Ohnishi T; Yoshikawa K; Ooesterwijk E
    Mol Carcinog; 2000 Mar; 27(3):184-9. PubMed ID: 10708480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer.
    Kaluz S; Kaluzová M; Stanbridge EJ
    Cancer Res; 2003 Mar; 63(5):917-22. PubMed ID: 12615703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
    Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
    Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.
    Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
    Am J Pathol; 2011 Feb; 178(2):515-24. PubMed ID: 21281785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
    Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
    Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J; Li G; Gentil-Perret A; Gigante M
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers.
    Chen J; Röcken C; Hoffmann J; Krüger S; Lendeckel U; Rocco A; Pastorekova S; Malfertheiner P; Ebert MP
    Gut; 2005 Jul; 54(7):920-7. PubMed ID: 15951534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma.
    Lieskovská J; Opavský R; Záciková L; Glasová M; Pastorek J; Pastoreková S
    Neoplasma; 1999; 46(1):17-24. PubMed ID: 10355529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.
    Said HM; Staab A; Hagemann C; Vince GH; Katzer A; Flentje M; Vordermark D
    J Neurooncol; 2007 Jan; 81(1):27-38. PubMed ID: 16944313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.
    Lim HY; Ahn M; Chung HC; Gardner TA; Kao C; Lee SJ; Kim SJ
    Cancer Gene Ther; 2004 Aug; 11(8):532-8. PubMed ID: 15167900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.